ELEV — Elevation Oncology Share News
0.000.00%
Last trade - 00:00Elevation Oncology rises on CEO, CFO appointments
Brief: Elevation Oncology Appoints Joseph Ferra As CEO And Promotes Tammy Furlong To CFO
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp
U.S. STOCKS ON THE MOVE-Netflix, Adobe, Carvana
U.S. STOCKS ON THE MOVE-DocuSign, Tesla, Sientra
Elevation Oncology tumbles on $50 mln stock-and-warrants deal
Brief: Elevation Oncology Announces Pricing Of $50 Million Public Offering
Brief: Elevation Oncology Announces Launch Of Proposed Public Offering
Brief: Elevation Oncology Inc Says Phase 1 SYSA1801 (Eo-3021) Clinical Initial Data Showed Promising Signs Of Efficacy
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
Brief: Elevation Oncology Reports First Quarter 2023 Financial Results And Highlights Recent Business Achievements
U.S. RESEARCH ROUNDUP-Blackline, Harmonic, Thor Industries
U.S. STOCKS ON THE MOVE-Gold miners, Silver miners, BlackRock
U.S. STOCKS ON THE MOVE-Bluebird, World Wrestling Entertainment, Valero Energy
Elevation Oncology falls after CEO resigns
Brief: Elevation Oncology Announces CEO Transition, Pipeline Prioritization
U.S. RESEARCH ROUNDUP-Altice USA, C4 Therapeutics, Lincoln National
Brief: Elevation Oncology Reports Third Quarter 2022 Financial Results